Fredensborg, Denmark

Lene Karin Jespersen

USPTO Granted Patents = 2 


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lene Karin Jespersen: Innovator in Biodegradable Polymers

Introduction

Lene Karin Jespersen is a prominent inventor based in Fredensborg, Denmark. She has made significant contributions to the field of biodegradable polymers, particularly in medical applications. With a total of 2 patents, her work focuses on enhancing biocompatibility for soft tissue regeneration.

Latest Patents

Lene's latest patents include "Degradable hydrophilic block copolymers with improved biocompatibility for soft tissue regeneration." This patent discloses biodegradable polymers that can be used as scaffolds for supporting cell adhesion and tissue regeneration. The polymer formula involves a combination of poly(lactide-co-glycolide) residues and polyalkylene glycol units, ensuring a molecular weight of at least 20,000 g/mol.

Another notable patent is for a "Biodegradable scaffold with ECM material." This innovation incorporates discontinuous regions of Extra Cellular Matrix (ECM) into a biodegradable scaffold. This combination enhances the physical properties of the scaffold while providing reconstructive properties of the ECM, allowing for optimal cell in-growth.

Career Highlights

Lene works at Coloplast A/S, a company known for its commitment to developing innovative medical solutions. Her research and inventions have played a crucial role in advancing the field of tissue engineering and regenerative medicine.

Collaborations

Lene collaborates with esteemed colleagues such as Hanne Everland and Peter Sylvest Nielsen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lene Karin Jespersen's work in biodegradable polymers exemplifies the intersection of innovation and medical science. Her patents reflect a commitment to improving patient outcomes through advanced materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…